Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,421 | 338 | 96.1% |
| Entertainment | $189.98 | 3 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $2,263 | 106 | $0 (2022) |
| ABBVIE INC. | $1,282 | 51 | $0 (2024) |
| Alcon Vision LLC | $797.87 | 16 | $0 (2024) |
| Optos, Inc. | $712.99 | 10 | $0 (2020) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $665.59 | 47 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $524.89 | 21 | $0 (2023) |
| Shire North American Group Inc | $453.44 | 12 | $0 (2019) |
| Oyster Point Pharma, Inc. | $271.47 | 9 | $0 (2024) |
| Eyevance Pharmaceuticals LLC | $198.26 | 6 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $170.84 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,281 | 49 | ABBVIE INC. ($420.49) |
| 2023 | $1,249 | 55 | AbbVie Inc. ($556.03) |
| 2022 | $1,085 | 41 | ABBVIE INC. ($305.88) |
| 2021 | $918.27 | 38 | Allergan, Inc. ($470.48) |
| 2020 | $831.85 | 40 | Allergan, Inc. ($337.82) |
| 2019 | $1,082 | 44 | Allergan Inc. ($285.82) |
| 2018 | $1,214 | 36 | Allergan Inc. ($415.60) |
| 2017 | $1,100 | 39 | Allergan Inc. ($682.09) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $39.21 | General |
| Category: Glaucoma | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: EYE CARE | ||||||
| 12/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: EYE CARE | ||||||
| 10/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: EYE CARE | ||||||
| 10/28/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: OPTOMETRY | ||||||
| 10/03/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: EYE CARE | ||||||
| 09/23/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: EYE CARE | ||||||
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| 09/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Ophthalmology | ||||||
| 08/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Ophthalmology | ||||||
| 08/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: EYE CARE | ||||||
| 08/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: EYE CARE | ||||||
| 07/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Ophthalmology | ||||||
| 07/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Dry eyes | ||||||
| 07/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: EYE CARE | ||||||
| 07/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,969 | 4,223 | $1.0M | $202,008 |
| 2022 | 16 | 3,018 | 4,296 | $964,482 | $197,463 |
| 2021 | 13 | 2,358 | 3,244 | $724,305 | $159,130 |
| 2020 | 12 | 1,312 | 1,863 | $382,587 | $87,615 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 397 | 678 | $183,060 | $44,198 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 382 | 382 | $189,090 | $42,433 | 22.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 313 | 354 | $136,430 | $30,831 | 22.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 427 | 1,284 | $154,279 | $25,534 | 16.6% |
| 92250 | Photography of the retina | Office | 2023 | 673 | 698 | $150,070 | $18,023 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 123 | $40,060 | $10,557 | 26.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 196 | 219 | $43,800 | $9,954 | 22.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 48 | 48 | $21,840 | $4,993 | 22.9% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 19 | 29 | $28,875 | $4,979 | 17.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 135 | 142 | $19,170 | $3,587 | 18.7% |
| 92134 | Imaging of retina | Office | 2023 | 84 | 90 | $12,600 | $2,801 | 22.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 74 | 74 | $6,290 | $1,670 | 26.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 20 | 20 | $5,200 | $1,126 | 21.7% |
| 92025 | Ct scan of cornea | Office | 2023 | 16 | 16 | $4,000 | $464.27 | 11.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 51 | 51 | $2,550 | $435.61 | 17.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 15 | $3,480 | $421.91 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 334 | 334 | $165,330 | $39,010 | 23.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 385 | 605 | $159,165 | $38,123 | 24.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 326 | 365 | $137,225 | $31,128 | 22.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 457 | 1,350 | $160,685 | $27,386 | 17.0% |
| 92250 | Photography of the retina | Office | 2022 | 620 | 640 | $137,600 | $17,050 | 12.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 168 | 192 | $38,400 | $9,007 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 89 | $28,830 | $8,767 | 30.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 93 | 93 | $39,000 | $6,675 | 17.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 195 | 217 | $29,295 | $5,685 | 19.4% |
About Dr. Amanda Bachman, O.D
Dr. Amanda Bachman, O.D is a Optometrist healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396950788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amanda Bachman, O.D has received a total of $8,761 in payments from pharmaceutical and medical device companies, with $1,281 received in 2024. These payments were reported across 342 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($8,421).
As a Medicare-enrolled provider, Bachman has provided services to 9,657 Medicare beneficiaries, totaling 13,626 services with total Medicare billing of $646,215. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Bellaire, TX
- Active Since 05/11/2007
- Last Updated 07/08/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1396950788
Products in Payments
- LUMIGAN (Drug) $1,735
- XIIDRA (Drug) $632.25
- RESTASIS (Drug) $601.03
- Cequa (Drug) $505.90
- AcrySof (Device) $437.32
- RESTASIS MULTIDOSE (Drug) $333.22
- Monaco (Device) $282.97
- VUITY (Drug) $274.55
- TYRVAYA (Drug) $271.47
- P200DTx (Device) $240.04
- COMBIGAN (Drug) $212.49
- California (Device) $189.98
- EYLEA (Biological) $170.84
- DUREZOL (Drug) $167.02
- Clareon (Device) $164.79
- AcrySof IQ PanOptix (Device) $148.03
- RXSIGHT CONTACT LENS (Device) $132.08
- OZURDEX (Drug) $122.39
- ALPHAGAN P (Drug) $122.04
- Prokera (Device) $118.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Bellaire
Dr. Jill Autry, O.d, O.D
Optometrist — Payments: $231,640
Aamena Kazmi, O.d, O.D
Optometrist — Payments: $13,333
Dr. Christopher Allee, O.d, O.D
Optometrist — Payments: $8,882
Darcy Seaton, Od, OD
Optometrist — Payments: $8,403
Christopher Sek, Od, OD
Optometrist — Payments: $7,515
Julie Ngo, O.d, O.D
Optometrist — Payments: $7,330